Rose is an assistant managing editor at The American Journal of Managed Care® (AJMC®).
She has a BA in journalism & media studies and Spanish from Rutgers University. You can connect with Rose on LinkedIn.
Social Determinants of Health Impact Germline Testing Rates Among Patients With TNBC
June 4th 2023Barb Kunz, MS, LCGC, senior genetic counselor at the US Oncology Network, shared insight on a study of social determinants of health in the context of germline genetic testing for triple-negative breast cancer (TNBC) in the community oncology setting.
Read More
Osimertinib Shows Significant OS Benefit in Patients With Resected, EGFRm NSCLC
June 4th 2023Roy S. Herbst, MD, PhD, deputy director of Yale Cancer Center and lead investigator for ADAURA, said the results erase any doubts about the use of osimertinib in early non–small cell lung cancer (NSCLC) for patients with EGFR mutations.
Read More
Dr Dennis Slamon on What Sets the NATALEE Trial Apart From Other Breast Cancer Studies
June 3rd 2023Dennis Slamon, MD, PhD, lead investigator on the NATALEE trial of ribociclib plus hormonal therapy in hormone receptor–positive, HER2-negative early-stage breast cancer, discussed the study's broad population and potential payer reactions.
Read More
ATS 2023 Abstracts Highlight Risk Factors for COPD Outside of Smoking
May 24th 2023A range of posters presented at the 2023 American Thoracic Society (ATS) International Conference highlighted a plethora of risk factors for pulmonary conditions in adulthood outside of tobacco smoking history.
Read More
Comorbidities Among Patients With COPD Impact Outcomes, Require Further Research
May 24th 2023A symposium at the 2023 American Thoracic Society International Conference highlighted common comorbidities that warrant consideration in patients who present with chronic obstructive pulmonary disease (COPD).
Read More
Measuring and Addressing the Environmental Factors That Impact Social Determinants of Health
May 22nd 2023Quantifying social determinants of health and addressing the factors that allow disparities to persist will require standardized measurements and targeted interventions, said a panel of experts at the 2023 American Thoracic Society International Conference.
Read More
Dr Mark Socinski on the Importance of Targeted Therapy and Immunotherapy in NSCLC
May 21st 2023Mark A. Socinski, MD, executive director of the AdventHealth Cancer Institute, shared his thoughts on the most important recent advances in non–small cell lung cancer (NSCLC), including a better understanding of patients who may benefit from immunotherapy.
Read More
Phase 3 Study Finds Dupilumab Reduces COPD Exacerbations in Patients With Type 2 Inflammation
May 21st 2023In the phase 3 BOREAS study of patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation, patients treated with dupilumab experienced fewer COPD exacerbations, improved lung function, and improved quality of life compared with patients given a placebo.
Read More
Treatment Improves Outcomes in Patients With CRSwNP, Features of Obstructive Lung Disease
May 19th 2023In the phase 3 SINUS-24 and SINUS-52 trials, dupilumab improved clinical outcomes and and health-related quality of life among patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and clinical features of obstructive lung disease.
Read More
Osimertinib Plus Chemotherapy Improves PFS vs Osimertinib Alone in EGFRm NSCLC
May 17th 2023Osimertinib plus chemotherapy showed a statistically significant improvement in progression-free survival (PFS) vs osimertinib alone in patients with epidermal growth factor receptor–mutated (EGFRm) advanced non–small cell lung cancer (NSCLC)
Read More
ATS International Conference to Highlight Key Research and Themes in Respiratory Medicine
May 16th 2023This year’s American Thoracic Society (ATS) International Conference will spotlight not only the latest research in respiratory medicine, but also timely themes such as minority health equity, the effects of climate on health, and reducing gun violence through advocacy.
Read More
Substantial Racial Inequalities Exist in Opioid Use Disorder Treatment, Study Finds
May 12th 2023Despite similar health care utilization, White patients were much more likely to receive and fill prescriptions for medications to treat opioid use disorder (OUD) compared with Black or Hispanic patients in the months following a high-risk OUD event such as an overdose, a new study has found.
Read More
Mailing At-Home HPV Tests May Boost Cervical Cancer Screening Rates in Underscreened Women
May 11th 2023Mailing at-home human papillomavirus (HPV) self-collection tests and providing booking assistance for in-clinic screening visits nearly doubled the rate of cervical cancer screenings among underscreened women from low-income backgrounds vs offering scheduling assistance alone.
Read More
Patients With EoE Benefit From Systemic Treatment Regardless of Esophageal Dilation History
May 10th 2023Treatment with dupilumab demonstrated improvements in histological markers, symptoms, and endoscopic markers of eosinophilic esophagitis (EoE) regardless of previous history of esophageal dilation.
Read More
Chemotherapy Plus Cemiplimab Improves QOL vs Chemotherapy Alone in NSCLC
May 9th 2023An analysis of the EMPOWER‐Lung 3 trial found that the addition of cemiplimab to platinum chemotherapy for non–small cell lung cancer (NSCLC) was associated with improved patient quality of life (QOL) vs chemotherapy alone.
Read More
Certain Comorbidities May Predict Cardiovascular Event Risk After ADT for Prostate Cancer
May 5th 2023The presence of certain comorbidities prior to androgen deprivation therapy (ADT) for prostate cancer may be associated with a greater risk of cardiovascular events after starting ADT, recent research found.
Read More
Patients With Advanced Cancer With High TMB Show Favorable Outcomes on ICIs
May 5th 2023A recent study found that patients with advanced solid cancers with high tumor mutational burden (TMB) saw improved outcomes on immune checkpoint inhibitors (ICIs) compared with patients who had low-TMB cancers.
Read More
Dr Jeffrey Lancet Discusses the Evolving Therapy Landscape of AML
May 4th 2023Jeffrey E. Lancet, MD, chair of the Department of Malignant Hematology at Moffitt Cancer Center, gave insight on the evolving treatment landscape of acute myeloid leukemia (AML) and the potential of immunotherapy and targeted therapies going forward.
Read More
For Treatment Resistance in NSCLC, Repeat Biomarker Testing Is Key, Says Dr Mark Socinski
May 4th 2023Mark A. Socinski, MD, executive director of AdventHealth Cancer Institute, gave insight into treatment resistance and the importance of repeat biomarker testing at the time of disease progression in non–small cell lung cancer (NSCLC).
Read More
Patients With Prostate Cancer Most Concerned With ADT Cost, Delivery Method
May 4th 2023A cross-sectional survey of patient preferences found that the out-of-pocket cost of treatment was the most impactful attribute for patients when choosing an androgen deprivation therapy (ADTs) for their prostate cancer.
Read More
Liquid and Tissue Biopsy Can Be Complementary in NSCLC, Says Dr Mark Socinski
April 29th 2023Mark A. Socinski, MD, executive director of the AdventHealth Cancer Institute, shares his insight on liquid- and tissue-based biopsies and their clinical utility in non–small cell lung cancer (NSCLC).
Read More
Value-Based Care: Is It Possible for All Providers to Succeed?
April 29th 2023Craig D. Pederson, principal at Insight Health Care Partners, discussed the evolving landscape of value-based care and challenges to implementation from the provider perspective during his keynote presentation at the National Association of Managed Care Physicians (NAMCP) Spring Managed Care Forum 2023.
Read More
How Chronic Care Management Can Benefit Providers and Patients
April 28th 2023A session led by Irina Koyfman, DNP, NP-C, RN, at the National Association of Managed Care Physicians (NAMCP) Spring Managed Care Forum 2023 detailed the potential of chronic care management billing for physicians who are not currently doing it and recommendations for optimizing the process.
Read More